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oTATE-OF-THE-ART PAPER1001Iron Overload Cardiomyopathyradeep Gujja, Douglas R. Rosing, Dorothy J. Tripodi, Yukitaka Shizukuda
ujja and colleagues review the pathophysiology, diagnosis, and treatment of iron overload
ardiomyopathy. Excessive iron accumulates either from increased absorption, as seen in
ereditary hemochromatosis, or from increased transfusions for diseases such as sickle cell
nemia. Serum markers including transferrin saturation and ferritin are useful, but not
efinitive. Magnetic resonance imaging can accurately quantify cardiac iron load and identify
arly cardiac dysfunction. Phlebotomy and chelating drugs are currently the standard therapy,
ut are suboptimal. The potential role of gene therapy, hepcidin, and L-type calcium-channel
lockers is reviewed.VIEWPOINT IEWPOINT1013The Routine Use of Oxygen in Cardiac Patients May Be Harmfulaman Moradkhan, Lawrence I. Sinoway
he use of supplemental oxygen is routine in cardiac patients and is an American College of
ardiology/American Heart Association Class IIa recommendation for all patients with
nstable angina/non–ST-segment elevation myocardial infarction (STEMI) and
ncomplicated STEMI within the first 6 h after presentation. In these conditions, inadvertent
yperoxia commonly occurs because it is not perceived to be detrimental. Moradkhan and
inoway challenge the assumption that oxygen is harmless by reviewing the evidence that
uggests that hyperoxia can cause the generation of reactive oxygen species and vasoconstriction,
hich reduces coronary blood flow. The authors suggest that high-quality studies are needed
o address this issue and determine if there is any therapeutic rationale for the routine use of
xygen in cardiac patients without hypoxia.(continued on page A-20)
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ELINICAL TRIAL1017Switching From Clopidogrel to Prasugrel Produces Further Platelet Inhibitionon
 (%
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Placebo LD/Prasugrel 10 mg MD (n=36)
Prasugrel 60 mg LD/10 mg MD (n=31) 
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0 2 24 4 6 8 10 12 1412ominick J. Angiolillo, Jorge F. Saucedo, Roger DeRaad, Andrew L. Frelinger, Paul A. Gurbel,
imothy M. Costigan, Joseph A. Jakubowski, Clement K. Ojeh, Mark B. Effron, for the SWAP Investigators
ngiolillo and colleagues measured the pharmacodynamic response of switching patients on
aintenance-phase clopidogrel therapy to prasugrel. Patients currently on clopidogrel 75 mg
nd aspirin were randomized to 1 of the following 3 treatments: placebo loading dose (LD)/
lopidogrel 75 mg maintenance dose (MD); placebo LD/prasugrel 10 mg MD; or prasugrel
0 mg LD/10 mg MD. Platelet function was evaluated at 2 h, 24 h, 7 days, and 14 days.
here was a significant decrease in maximum adenosine diphosphate (ADP)-induced platelet
ggregation by light transmittance aggregometry at 1 week with both of the prasugrel
egimens compared with clopidogrel MD. A prasugrel LD resulted in higher platelet
nhibition within 2 h. In patients on MD clopidogrel therapy, switching from clopidogrel to
rasugrel produces greater platelet inhibition.NTERVENTIONAL CARDIOLOGY1024Greater P2Y Inhibition Associated With Decreased Endothelial Injury During PCI12
aurent Bonello, Karim Harhouri, Florence Sabatier, Laurence Camoin-Jau, Laurent Arnaud,
arine Baumstarck-Barrau, Omar Ait-Mokhtar, François Roubille, Christophe Piot, Nathalie Lesavre,
ranck Paganelli, Françoise Dignat-George
echanical damage alters the regulatory functions and the integrity of the endothelium and
an cause endothelial cells to detach. Circulating endothelial cells (CEC) are mature
ndothelial cells that have become detached. Previous studies have suggested that P2Y12, in
ddition to promoting platelet aggregation, may be important for maintaining endothelial
ealth. Bonello and colleagues measured CEC at baseline and 6 h and 24 h post-procedure
n patients with stable angina undergoing percutaneous coronary intervention (PCI) who
eceived a 600-mg loading dose of clopidogrel. Adenosine diphosphate (ADP) receptor
2Y12 blockade was assessed by the vasodilator-stimulated phosphoprotein (VASP). PCI
nduced a significant rise in CEC levels at 6 h; CEC peak value was significantly higher in
atients with high on-treatment platelet reactivity compared with good responders, and there
as a direct correlation between CEC delta-change and the VASP index. ADP receptor
2Y12 blockade reduces the endothelial injury during PCI and may underlie some of the
linical benefit of clopidogrel for patients undergoing PCI.
ditorial Comment: Goran Rudež, Hendricus J. Duckers, Maarten L. Simoons, p. 1032(continued on page A-25)
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ETHEROSCLEROSIS1034CIMT and CAC Linked Primarily to Elevated Low-Density Lipoprotein-Cholesterolathmaja Paramsothy, Robert H. Knopp, Alain G. Bertoni, Roger S. Blumenthal, Bruce A. Wasserman,
ichael Y. Tsai, Tessa Rue, Nathan D. Wong, Susan R. Heckbert
aramsothy and colleagues used data from the MESA (Multi-Ethnic Study of
therosclerosis) trial to investigate if the 5 major patterns of dyslipidemia have different
ssociations with carotid intima-media thickness (CIMT) and coronary artery calcium
CAC). The 5 major dyslipidemias were defined by National Cholesterol Education
rogram/Adult Treatment Panel-III guideline thresholds: combined hyperlipidemia,
ypercholesterolemia, dyslipidemia of metabolic syndrome, low high-density lipoprotein
holesterol, and hypertriglyceridemia. Nearly 5,000 subjects in the MESA trial who did not
ave diabetes or coronary artery disease were classified into one of the dyslipidemias or
efined as normolipemic (NL). Only those with combined hyperlipidemia and
ypercholesterolemia demonstrated both increased CIMT and CAC compared with NL
atients. Combined hyperlipidemia and simple hypercholesterolemia, in which the primary
bnormality is elevated low-density lipoprotein cholesterol (160 mg/dl), are associated with
ubclinical atherosclerosis.ditorial Comment: G. B. John Mancini, Jiri Frohlich, p. 1042IOMARKERS IN STROKE1045ANP Predicts Stroke Mortality and May Help Identify Etiologyira Katan, Felix Fluri, Philipp Schuetz, Nils G. Morgenthaler, Christian Zweifel, Roland Bingisser,
udwig Kappos, Andreas Steck, Stefan T. Engelter, Beat Müller, Mirjam Christ-Crain
mmunohistochemical studies suggest that cerebral ischemia directly induces A-type
atriuretic peptide (ANP) secretion in brain tissue, and genetic studies suggest a further link
etween ANP and the risk of ischemic stroke. Katan and colleagues investigated the
rognostic value of mid-regional pro-atrial natriuretic peptide (MR-proANP) in patients with
cute ischemic stroke. The discriminatory accuracy of MR-proANP to predict death was
omparable to the National Institutes of Health Stroke Score (NIHSS); combining the 2
ffered further significant improvements. MR-proANP was also useful for predicting
unctional outcome and for identifying those whose stroke was of a cardioembolic source.
R-proANP appears to be a useful prognostic marker in patients who present with stroke
ymptoms.
ditorial Comment: Christopher B. Granger, Daniel T. Laskowitz, p. 1054(continued on page A-32)
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dARDIAC IMAGING1056SENC Imaging Can Predict Functional Recovery After MIirja Neizel, Grigorios Korosoglou, Dirk Lossnitzer, Harald Kühl, Rainer Hoffmann, Christina Ocklenburg,
vangelos Giannitsis, Nael F. Osman, Hugo A. Katus, Henning Steen
eizel and colleagues evaluated the usefulness of systolic and diastolic deformation indexes
etermined by cardiac magnetic resonance strain-encoded (SENC) imaging to predict
unctional recovery 6 months after reperfused ST-segment elevation myocardial infarction
STEMI). Cine, SENC, and late gadolinium enhancement (LGE) images were acquired
days and 6 months after STEMI. Peak systolic circumferential strain (Ecc) and early
iastolic strain rate (Ecc/s) were calculated for each segment. Ecc/s and LGE had similar
redictive utility. Segmental diastolic function may be useful to predict persistent severe
ysfunction in patients after STEMI, and it does not require contrast administration.
